Article
CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin.
International journal of cancer - 1 May 2010
Küsters-Vandevelde Heidi V N, Van Leeuwen Arjanne, Verdijk Marian A J, de Koning Maurits N C, Quint Wim G V, Melchers Willem J G, Ligtenberg Marjolijn J L, Blokx Willeke A M
Abstract excerpt
Genetic alterations in metastatic cutaneous squamous cell carcinoma (CSCC) which might serve as prognostic biomarkers are not well investigated. We investigated the mutation status and protein expression of the CDKN2A (INK4a-ARF) and TP53 genes in metastatic CSCCs and correlated this with clinicopathological variables, HPV presence, and survival data. Sequence analysis was performed on formalin-fixed and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
